Get Mystery Box with random crypto!

UPDATES IN MEDICINE

Logo of telegram channel updates_in_medicine — UPDATES IN MEDICINE U
Logo of telegram channel updates_in_medicine — UPDATES IN MEDICINE
Channel address: @updates_in_medicine
Categories: Health
Language: English
Subscribers: 17.70K
Description from channel

Latest trending medical News, Research and Guidelines
Discussion Group
https://t.me/Professional_Medical_Discussion

Ratings & Reviews

2.67

3 reviews

Reviews can be left only by registered users. All reviews are moderated by admins.

5 stars

0

4 stars

1

3 stars

1

2 stars

0

1 stars

1


The latest Messages 4

2022-05-17 19:46:28 ​​ Beta agonist Alone or Combined Therapy as Reliever in Asthma

Albuterol–Budesonide Rescue Inhaler for Asthma


Among patients with moderate-to-severe asthma who were receiving a range of inhaled glucocorticoid maintenance therapies, the risk of severe asthma exacerbation was significantly lower with as-needed use of a fixed-dose combination of 180 μg of albuterol and 160 μg of budesonide than with albuterol alone.


@Updates_in_Medicine
1.2K viewsedited  16:46
Open / Comment
2022-05-16 15:14:05 @Updates_in_Medicine
1.4K viewsedited  12:14
Open / Comment
2022-05-16 15:13:46 ​​ First Fatty Liver Guidelines for Endocrinology, Primary Care

American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings
Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD)


Endocrinologists and primary care docs 'need to be the ones who are diagnosing and managing non-alcoholic fatty liver disease because there just aren't enough liver specialists to do that,' says author.


@Updates_in_Medicine
2.0K viewsedited  12:13
Open / Comment
2022-05-14 08:06:19 @Updates_in_Medicine
649 viewsedited  05:06
Open / Comment
2022-05-14 08:06:02 ​​ Treatment of Mild Chronic Hypertension during Pregnancy

Pregnant women with mild chronic hypertension were randomly assigned to receive medication targeting a normal blood pressure (<140/90 mm Hg) or to receive no treatment unless severe hypertension (>160/105 mm Hg) developed. The incidence of adverse maternal and neonatal outcomes was significantly lower in the active-treatment group, without an increase in low birth weight.


@Updates_in_Medicine
946 viewsedited  05:06
Open / Comment
2022-05-07 09:29:46 ​​ Latest on Mysterious Hepatitis in Children


Overview: Children with Hepatitis of Unknown Cause | CDC

https://www.cdc.gov/ncird/investigation/hepatitis-unknown-cause/overview-what-to-know.html


Mysterious Hepatitis in Kids: What We Know and Don't Know Now
https://www.medscape.com/viewarticle/973614?src=rss


CDC Investigating More Than 100 Severe Pediatric Hepatitis Cases
https://www.medscape.com/viewarticle/973610?src=rss


C.D.C. Is Investigating 109 Cases of Hepatitis in Children, Including 5 Deaths
https://www.nytimes.com/2022/05/06/health/cdc-hepatitis-children.html


@Updates_in_Medicine
2.8K viewsedited  06:29
Open / Comment
2022-05-06 09:16:15 @Updates_in_Medicine
1.8K viewsedited  06:16
Open / Comment
2022-05-06 09:15:46 ​​ Whom to Treat for Primary Prevention of Atherosclerotic Cardiovascular Disease

USPSTF Recommendation Statement on Aspirin Use to Prevent Cardiovascular Disease



The US Preventive Services Task Force (USPSTF) has released its updated 2022 recommendations, supported by an updated evidence report, to guide the use of low-dose aspirin for the primary prevention of atherosclerotic cardiovascular disease (ASCVD), changing the age ranges and recommendation grades and focusing on preventing ASCVD events.


@Updates_in_Medicine
2.6K viewsedited  06:15
Open / Comment
2022-05-01 13:10:40 @Updates_in_Medicine
434 viewsedited  10:10
Open / Comment
2022-05-01 13:10:23 ​​ CT or Invasive Coronary Angiography in Stable Chest Pain
The DISCHARGE Trial

In this multicenter trial, 3561 patients with stable chest pain at intermediate risk for obstructive coronary artery disease were randomly assigned to undergo CT or invasive coronary angiography. Over 3.5 years of follow-up, there was no significant between-group difference in the risk of major adverse cardiovascular events. Major procedure-related complications were less common with CT.


@Updates_in_Medicine
668 viewsedited  10:10
Open / Comment